{"id": "379736", "url": "https://fevir.net/resources/Evidence/379736", "meta": {"versionId": "4", "lastUpdated": "2025-07-01T18:46:16.355Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group", "author": [{"name": "Joanne Dehnbostel"}], "citeAs": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379736. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379736. Computable resource at: https://fevir.net/resources/Evidence/379736#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "display": "Outcome Measure Report for QUARTET USA Trial", "reference": "Composition/375280"}}], "statistic": [{"note": [{"text": "The statistic as reported appears to use the number of participants without missing data (29) as the denominator rather than the number analyzed (32) as suggested in the paper. Either way, the reported percentage does not match the value reported for this outcome in ClinicalTrials.gov results reporting (66.7% at https://fevir.net/resources/Composition/370504)"}], "quantity": {"code": "%", "unit": "%", "value": 65.51724137931035, "system": "http://unitsofmeasure.org"}, "sampleSize": {"knownDataCount": 29, "numberOfParticipants": 32, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed", "valueUnsignedInt": 32}]}, "statisticType": {"coding": [{"code": "STATO:0000639", "system": "https://fevir.net/sevco", "display": "percentage"}]}, "numberAffected": 19}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "379736", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "Evidence", "variableDefinition": [{"observed": {"type": "Group", "display": "QUARTET USA Trial Quadpill group", "reference": "Group/375175"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Hypertension Control at 12 weeks", "reference": "EvidenceVariable/375202"}, "variableRole": "outcome"}], "name": "Evidence_for_Results_for_Hypertension_Control_at_12_weeks_in_QUARTET_USA_Trial_Quadpill_group", "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}